SIGA Technologies, Inc. (SIGA)
NASDAQ: SIGA · Real-Time Price · USD
5.55
-0.02 (-0.36%)
At close: Mar 28, 2025, 4:00 PM
5.49
-0.06 (-1.01%)
After-hours: Mar 28, 2025, 6:21 PM EDT
SIGA Technologies Revenue
In the year 2024, SIGA Technologies had annual revenue of $138.72M, down -0.86%. SIGA Technologies had revenue of $81.47M in the quarter ending December 31, 2024, a decrease of -30.06%.
Revenue (ttm)
$138.72M
Revenue Growth
-0.86%
P/S Ratio
2.85
Revenue / Employee
$3,015,638
Employees
46
Market Cap
396.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 138.72M | -1.20M | -0.86% |
Dec 31, 2023 | 139.92M | 29.14M | 26.31% |
Dec 31, 2022 | 110.78M | -22.89M | -17.13% |
Dec 31, 2021 | 133.67M | 8.71M | 6.97% |
Dec 31, 2020 | 124.96M | 98.22M | 367.28% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSIGA News
- 10 days ago - SIGA Appoints Retired General John M. Keane to its Board of Directors - GlobeNewsWire
- 17 days ago - SIGA Technologies, Inc. (SIGA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 17 days ago - SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024 - GlobeNewsWire
- 24 days ago - SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses - GlobeNewsWire
- 3 months ago - Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced - GlobeNewsWire
- 4 months ago - SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook - Seeking Alpha
- 4 months ago - SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket - Seeking Alpha